BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23985681)

  • 21. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
    McCann JL; Cristini A; Law EK; Lee SY; Tellier M; Carpenter MA; Beghè C; Kim JJ; Sanchez A; Jarvis MC; Stefanovska B; Temiz NA; Bergstrom EN; Salamango DJ; Brown MR; Murphy S; Alexandrov LB; Miller KM; Gromak N; Harris RS
    Nat Genet; 2023 Oct; 55(10):1721-1734. PubMed ID: 37735199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
    Wang S; Jia M; He Z; Liu XS
    Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.
    Cannataro VL; Gaffney SG; Sasaki T; Issaeva N; Grewal NKS; Grandis JR; Yarbrough WG; Burtness B; Anderson KS; Townsend JP
    Oncogene; 2019 May; 38(18):3475-3487. PubMed ID: 30647454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3B: pathological consequences of an innate immune DNA mutator.
    Burns MB; Leonard B; Harris RS
    Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
    Cannataro VL; Kudalkar S; Dasari K; Gaffney SG; Lazowski HM; Jackson LK; Yildiz I; Das RK; Gould Rothberg BE; Anderson KS; Townsend JP
    Lung Cancer; 2022 Sep; 171():34-41. PubMed ID: 35872531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
    Caswell D; Swanton C
    Cancer Res; 2023 Feb; 83(4):487-488. PubMed ID: 36789568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.
    Wu J; Li N; Zhu L; Zhen D; Li M; Chen H; Ye M; Wei Y; Shao G
    BMC Bioinformatics; 2022 Aug; 23(1):312. PubMed ID: 35918642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOBEC3B is an enzymatic source of mutation in breast cancer.
    Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
    Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA replication stress: a source of APOBEC3B expression in breast cancer.
    Cescon DW; Haibe-Kains B
    Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
    Liu W; Newhall KP; Khani F; Barlow L; Nguyen D; Gu L; Eng K; Bhinder B; Uppal M; Récapet C; Sboner A; Ross SR; Elemento O; Chelico L; Faltas BM
    Cancer Res; 2023 Feb; 83(4):506-520. PubMed ID: 36480186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.
    Shi K; Carpenter MA; Kurahashi K; Harris RS; Aihara H
    J Biol Chem; 2015 Nov; 290(47):28120-28130. PubMed ID: 26416889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer.
    Li X; Wang Y; Deng S; Zhu G; Wang C; Johnson NA; Zhang Z; Tirado CR; Xu Y; Metang LA; Gonzalez J; Mukherji A; Ye J; Yang Y; Peng W; Tang Y; Hofstad M; Xie Z; Yoon H; Chen L; Liu X; Chen S; Zhu H; Strand D; Liang H; Raj G; He HH; Mendell JT; Li B; Wang T; Mu P
    Cancer Cell; 2023 Aug; 41(8):1427-1449.e12. PubMed ID: 37478850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
    Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
    J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The APOBEC3B cytidine deaminase is an adenovirus restriction factor.
    Lejeune N; Mathieu S; Decloux A; Poulain F; Blockx Z; Raymond KA; Willemart K; Vartanian JP; Suspène R; Gillet NA
    PLoS Pathog; 2023 Feb; 19(2):e1011156. PubMed ID: 36745676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
    Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
    Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.